Behind the Bonitas outrage
The anger and frustration displayed by Bonitas members is in stark contrast to the distinct lack of urgency from the authorities…
Suggestions
Gap cover: the back-up plan for medical aid shortfalls
With healthcare costs rising and medical aids under pressure, gap cover fills a growing financial hole – but take-up remains stubbornly low…
Discovery, humbled by poor crisis management, does a U-turn
Discovery’s ham-fisted efforts to recoup money paid in error to some members is a lesson in how not to manage a crisis…
How drones are rewiring Africa’s development story
Drones are playing a productive role in Africa, plugging the many service and infrastructure gaps that exist…
Investors flee amid Aspen’s contract horror
A major contract dispute will slash Aspen's profits. Investors are rattled – and confidence in the company is ebbing away…
Trump orders USAID-funded HIV organisations in South Africa to shut down
USAID-funded projects focused on HIV prevention and treatment, including TB programmes, received termination letters overnight…
Aspen: Still a case of ‘when’, not ‘if’?
The least favourite part of Aspen CEO Stephen Saad’s job, it seems, is delivering the firm’s twice-yearly results presentations. It’s hard to blame him…
Most Read
South Africa, we are in terminal trouble
The country is being forced to reset its ambitions at…
Hyperscalers or just hype? How to build your AI watchlist
Picking your way through a blanket ‘AI-trade’ has become that…
Mind your market multiples
SpaceX, Anthropic, OpenAI: what the IPO class of 2026 (and…
Inside EasyEquities’ $10.75m AI play
Purple’s first major offshore deal could move the owner of…
